Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Neuro-Oncology|November 5, 2019
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?Marijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2015
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patientsChantal Quinten, Corneel Coens, Irina Ghislain, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2022
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation studyAbigirl Machingura, Mekdes Taye, Jammbe Musoro, et al.
Neuro-Oncology Practice|December 11, 2020
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patientsMarijke B Coomans, Martin J B Taphoorn, Neil K Aaronson, et al.
Neuro-Oncology Advances|January 7, 2021
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modelingMarijke B Coomans, Linda Dirven, Neil K Aaronson, et al.
Eclinicalmedicine|April 9, 2025
Prognostic value of baseline EORTC QLQ-C30 scores for overall survival across 46 clinical trials covering 17 cancer types: a validation studyLuigi Lim, Abigirl Machingura, Mekdes Taye, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
The Oncologist|January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysisOgechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Pageof 5